Tang-du Hospital

This early-stage study tests whether ofatumumab can reduce relapse rates in people with a rare autoimmune disease called NMOSD. Five adults who have had at least two relapses in the past two years will receive the drug. Researchers will track relapses and disability changes over …

This study tests whether baricitinib, a drug used for arthritis, can help people recover from moderate to severe traumatic brain injury with bleeding. About 100 adults will receive the drug within 24 hours of injury. The main goal is to see if it improves brain function and reduc…

This study tests whether giving the targeted drug ensartinib along with chemotherapy before surgery can shrink tumors in people with ALK-positive non-small cell lung cancer. About 20 adults with stage II to IIIB lung cancer will receive the combination for 9 weeks, then have surg…

This study tests whether giving a combination of two drugs (nimotuzumab and toripalimab) plus chemotherapy before surgery can help shrink tumors in people with locally advanced tonsillar cancer. About 10 participants will receive the treatment and then have surgery to remove any …

This study tests whether giving the steroid methylprednisolone right after a stroke clot removal procedure can improve recovery and reduce complications. About 210 adults who had a major stroke from a blocked artery in the brain will be randomly assigned to receive either the ste…